INSL3 in the benign hyperplastic and neoplastic human prostate gland

  • Authors:
    • Thomas Klonisch
    • Harald Müller-Huesmann
    • Maria Riedel
    • Astrid Kehlen
    • Joanna Bialek
    • Yvonne Radestock
    • Hans-Juergen Holzhausen
    • Klaus Steger
    • Martin Ludwig
    • Wolfgang Weidner
    • Cuong Hoang-Vu
    • Sabine Hombach-Klonisch
  • View Affiliations

  • Published online on: August 1, 2005     https://doi.org/10.3892/ijo.27.2.307
  • Pages: 307-315
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The human prostate gland is a well known source of H1 and H2 relaxin but information is lacking on the expression and potential role of the INSL3 peptide hormone within the prostate gland. In the present study we have investigated the expression of human INSL3 in patients with benign prostate hyperplasia (BPH), prostate intraepithelial neoplasia (PIN) and prostate carcinoma tissues. Of the prostate epithelial cells, strongest INSL3 expression was detected in the basal epithelial cell compartment. Weaker INSL3 mRNA expression and immunoreactive INSL3 production were observed in secretory epithelial cells and in interstitial smooth muscle cells. Prostate epithelial cells were also a source for transcripts encoding the INSL3 receptor LGR8 suggesting the presence of an autocrine/paracrine INSL3-LGR8 ligand-receptor system within the human prostate. Three human prostate carcinoma cell lines displayed differential gene activity for INSL3 and LGR8. While LNCaP was devoid of INSL3, the androgen-insensitive PC-3 and the stromal prostate cell line hPCP co-expressed INSL3 and LGR8 transcripts. In addition to expressing INSL3 mRNA, the LGR8-negative DU-145 also expressed an INSL3 splice form formerly demonstrated in thyroid carcinoma cells. When incubated with recombinant INSL3, PC-3 cells showed significantly increased intracellular cAMP levels indicating functional LGR8 receptors. INSL3 did not alter the proliferative or metabolic activity of PC-3 carcinoma cells. Instead, PC-3 responded to INSL3 with significantly enhanced tumor cell motility and a transcriptional down-regulation of ErbB receptors and EGF. All-trans-retinoic acid was demonstrated in PC-3 to up-regulate LGR8 gene activity in a dose- and time-dependent manner while having no effect on INSL3 gene activity. In conclusion, we have identified a functional INSL3-LGR8 ligand-receptor system in human prostate carcinoma cells.

Related Articles

Journal Cover

August 2005
Volume 27 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Klonisch T, Müller-Huesmann H, Riedel M, Kehlen A, Bialek J, Radestock Y, Holzhausen H, Steger K, Ludwig M, Weidner W, Weidner W, et al: INSL3 in the benign hyperplastic and neoplastic human prostate gland. Int J Oncol 27: 307-315, 2005
APA
Klonisch, T., Müller-Huesmann, H., Riedel, M., Kehlen, A., Bialek, J., Radestock, Y. ... Hombach-Klonisch, S. (2005). INSL3 in the benign hyperplastic and neoplastic human prostate gland. International Journal of Oncology, 27, 307-315. https://doi.org/10.3892/ijo.27.2.307
MLA
Klonisch, T., Müller-Huesmann, H., Riedel, M., Kehlen, A., Bialek, J., Radestock, Y., Holzhausen, H., Steger, K., Ludwig, M., Weidner, W., Hoang-Vu, C., Hombach-Klonisch, S."INSL3 in the benign hyperplastic and neoplastic human prostate gland". International Journal of Oncology 27.2 (2005): 307-315.
Chicago
Klonisch, T., Müller-Huesmann, H., Riedel, M., Kehlen, A., Bialek, J., Radestock, Y., Holzhausen, H., Steger, K., Ludwig, M., Weidner, W., Hoang-Vu, C., Hombach-Klonisch, S."INSL3 in the benign hyperplastic and neoplastic human prostate gland". International Journal of Oncology 27, no. 2 (2005): 307-315. https://doi.org/10.3892/ijo.27.2.307